Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C22H16N2O5S |
| Molecular Weight | 420.438 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC1=CC=C(C=C1O)C(=O)NC2=NC(=C(S2)C3=CC=CC=C3)C4=CC=C(O)C(O)=C4
InChI
InChIKey=LGGDLPSXAGQFSG-UHFFFAOYSA-N
InChI=1S/C22H16N2O5S/c25-15-8-6-13(10-17(15)27)19-20(12-4-2-1-3-5-12)30-22(23-19)24-21(29)14-7-9-16(26)18(28)11-14/h1-11,25-28H,(H,23,24,29)
| Molecular Formula | C22H16N2O5S |
| Molecular Weight | 420.438 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
COH-29 is an antimetabolite drug developed at City of Hope Cancer Center. Compound targets human ribonucleotide reductase, a key enzyme in the deoxyribonucleotide biosynthesis. In preclinical studies, COH-29 induced double-strand breaks in BRCA1-defective breast cancer cells and has been shown to reduce tumor growth in leukemia and ovarian cancer models. In 2015, COH-29 was licensed to a biotech company Novonco. The drug is being evaluated in phase 1 clinical trial for the treatment of patients with solid tumors.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 08:02:56 UTC 2023
by
admin
on
Sat Dec 16 08:02:56 UTC 2023
|
| Record UNII |
07802BU06S
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C2150
Created by
admin on Sat Dec 16 08:02:56 UTC 2023 , Edited by admin on Sat Dec 16 08:02:56 UTC 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
07802BU06S
Created by
admin on Sat Dec 16 08:02:56 UTC 2023 , Edited by admin on Sat Dec 16 08:02:56 UTC 2023
|
PRIMARY | |||
|
C114976
Created by
admin on Sat Dec 16 08:02:56 UTC 2023 , Edited by admin on Sat Dec 16 08:02:56 UTC 2023
|
PRIMARY | |||
|
44253415
Created by
admin on Sat Dec 16 08:02:56 UTC 2023 , Edited by admin on Sat Dec 16 08:02:56 UTC 2023
|
PRIMARY | |||
|
1190932-38-7
Created by
admin on Sat Dec 16 08:02:56 UTC 2023 , Edited by admin on Sat Dec 16 08:02:56 UTC 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> INHIBITOR |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
